The present invention relates to genetic mutations in mitochondrial cytochrome c oxidase genes that segregate with Alzheimer's disease (AD). The invention provides methods for detecting such mutations, as a diagnostic for Alzheimer's Disease, either before or after the onset of clinical symptoms. The invention further provides treatment of cytochrome c oxidase dysfunction.
本发明涉及与阿尔茨海默病(AD)相关的线粒体细胞色素c氧化酶
基因的遗传突变。该发明提供了检测这种突变的方法,作为阿尔茨海默病的诊断方法,无论是在临床症状出现之前还是之后。本发明还提供了治疗细胞色素c氧化酶功能障碍的方法。